Advertisement

Topics

Cancer Reports

14:34 EST 15th December 2018 | BioPortfolio

The Wistar Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryThe Wistar Institute Wistar is a biomedical research institute that carries out medical research and training. The institute performs research in the areas of cancer, infectious diseases, immunology and vaccine development. It also conducts research on genes, gene expression, and DNA biology; cancer biology; translational research; and virology. Wistar develops vaccines against rotavirus, r...

Verisante Technology Inc Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryVerisante Technology Inc Verisante is a medical device company that develops and commercializes systems for the early detection of cancer. The company's key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a...

GeneNews Ltd GEN Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryGeneNews Ltd GeneNews is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNews offers biomarkers for detect disease, stage diseases, monitor and progression and determine treatment...

Cascadian Therapeutics Inc CASC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryCascadian Therapeutics Inc Cascadian, formerly Oncothyreon Inc is a clinicalstage biotechnology company that develops therapeutic products for the treatment of cancer. The company's lead clinicalstage product candidate includes ONT380, an orally active and selective smallmolecule HER2 inhibitor which is intended for the treatment of HER2positive HER2+ metastatic breast cancer. It also devel...

Transitional Cell Cancer Urothelial Cell Cancer Global Clinical Trials Review, H2, 2018 [Report Updated: 31082018] Prices from USD $2125

Transitional Cell Cancer Urothelial Cell Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Transitional Cell Cancer Urothelial Cell Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Transitional Cell Cancer Urothelial Cell Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Transitional ...

QIMR Berghofer Medical Research Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryQIMR Berghofer Medical Research Institute QIMR, formerly Queensland Institute of Medical Research is a medical research institute that offers education and research programs. The institute offers its research programs in the areas of mental health, cancer, infectious disease, and complex disorders. Its cancer research areas includes breast cancer, blood cancer, brain cancer, lung cancer, en...

True Diagnostics Inc Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryTrue Diagnostics Inc True Diagnostics is a research, development and manufacturing company that offers invitro immunodiagnostic test systems and reagents. The company provides diagnostics such as self testing, point of care testing and companion diagnostics. It offers trueDX platform technology including trueDX reader, trueDX software, trueDXTSH test, trueDXT4 test, trueDXGneg test, trueDXG...

National Cancer Centre Singapore Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryNational Cancer Centre Singapore NCCS is a cancer research centre that offers research, education, clinical services, and patient care services. The centre offers services such as medical oncology, oncologic imaging, palliative medicine, pharmacy, psychosocial oncology, public education, radiation oncology and surgical oncology. It also offers training, upgrade and refresher courses in onco...

Anchiano Therapeutics Ltd BICL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAnchiano Therapeutics Ltd Anchiano formerly BioCancell Ltd, focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancerrelated diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The company's product pipeline candidates is being evaluated for the treatment of bladder cancer, ovarian cancer and pancrea...

Abramson Cancer Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryAbramson Cancer Center Abramson formerly Penn Medicine's Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include integrative medicine and wellness, nutritional counseling, pastoral care, patient education and psycho...

Squamous NonSmall Cell Lung Cancer Global Clinical Trials Review, H2, 2018 [Report Updated: 31082018] Prices from USD $2125

Squamous NonSmall Cell Lung Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Squamous NonSmall Cell Lung Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Squamous NonSmall Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Squamous NonSmall Cell Lung Cancer. Report includes ...

bluebird bio Inc BLUE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryBluebird Bio Inc bluebird bio is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti D for the treatment of cerebral adrenoleu...

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 [Report Updated: 31082018] Prices from USD $3396

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018SummaryThis report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for pancreatic and bile duct cancer, and features dormant and discontinued products.Pancreatic canc...

Head And Neck Cancer Pipeline Review, H2 2018 [Report Updated: 30102018] Prices from USD $2500

Head And Neck Cancer Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Pipeline Review, H2 2018, provides an overview of the Head And Neck Cancer Oncology pipeline landscape.Head and Neck Cancer is a cancer that arises in the head or neck region in the nasal cavity, sinuses, lips, mouth, salivary glands, throat...

Salivary Gland Cancer Global Clinical Trials Review, H2, 2018 [Report Updated: 31072018] Prices from USD $2125

Salivary Gland Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Salivary Gland Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Salivary Gland Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Salivary Gland Cancer. Report includes an overview of trial numbers and their average enrol...

Cancer Research Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryCancer Research Institute CRI is a nonprofit cancer research organization that discovers and develops immunotherapy for treating various types of cancer. The organization offers clinical trials for breast cancer, colorectal cancer, lung cancer, melanoma and prostate cancer. Its programs comprise clinical accelerator, cancer immunology research, cancer immunotherapy symposium, and cancer imm...

Astellas Pharma Inc 4503 Financial and Strategic SWOT Analysis Review [Report Updated: 24102018] Prices from USD $125

Astellas Pharma Inc 4503 Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment y...

SmallCell Lung Cancer Global Clinical Trials Review, H2, 2018 [Report Updated: 31072018] Prices from USD $2125

SmallCell Lung Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, SmallCell Lung Cancer Global Clinical Trials Review, H2, 2018" provides an overview of SmallCell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on SmallCell Lung Cancer. Report includes an overview of trial numbers and their average enrol...

Aptose Biosciences Inc APTO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAptose Biosciences Inc Aptose is a clinicalstage biotechnology company which focuses on diagnostics, therapies and treatment for patients with lifethreatening cancers. The company advances in new therapeutics which focuses on cellular targets of cancer research coupled with companion diagnostics to identify patient with cancer. Its small molecule cancer therapeutics pipeline includes produc...

Immunooncology Development Trends and Opportunities [Report Updated: 01112018] Prices from USD $6796

Immunooncology Development Trends and OpportunitiesSummaryImmunooncology IO is the treatment of cancer with therapies that stimulate or suppress the body's own immune system. Several distinct modalities of IO therapy exist, including bispecific Tcell engaging monoclonal antibodies, cellular immunotherapy and adoptive cellular therapy, cancer vaccines, checkpoint modulating monoclonal antibodies, a...

Cancer Genetics Inc CGIX Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryCancer Genetics Inc CGI is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, nextgeneration sequencing and DNAFISH Probes. Its oncology tests and laboratory services offer critical genomic information to healthcare professionals, biopharma companies, and cancer centers. CGI provides clinical servi...

Amplia Therapeutics Ltd ATX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryAmplia Therapeutics Ltd Amplia Therapeutics, formerly Innate Therapeutics Ltd, is a pharmaceutical company with focus on the development of focal adhesion kinase FAK inhibitors for the treatment of cancer and fibrosis. Its lead drug candidate, AMP945, is a small molecule targeting focal adhesion kinase FAK in fibrotic tumors such as pancreatic and ovarian cancer; and the other drug candidat...

Peter MacCallum Cancer Centre Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryPeter MacCallum Cancer Centre Peter Mac is a provider of public health services. It serves as a cancer research, treatment and education centre. The centre provides wide range of services including diagnostic, radiation therapy, treatment, cancer information and support services. It works in collaboration with various organizations and networks domestically and across the globe to provide c...

Global Cancer mTOR Inhibitors Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Ureter Cancer Global Clinical Trials Review, H2, 2018 [Report Updated: 28092018] Prices from USD $2125

Ureter Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Ureter Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Ureter Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Ureter Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Cancer market research data and corporate reports here